Why are we running out of antibiotics? A look at the pharmaceutical development of one of the most life-saving class of drugs.

Topics discussed:

• The reasons behind the stagnant and declining antibiotic development pipeline
• New initiatives focused on stimulating the antibiotic market
• Strategies to spur the antibiotic development

Guests:

• Helen Boucher, MD. Professor of Medicine and Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Editor of AAC
• Karen Bush, PhD. Professor of Practice & Interim Director, Biotechnology Program Indiana University. Former Editor AAC.

Visit aac.asm.org to read current and archived issues of the Antimicrobial Agents and Chemotherapy journal.